Karen Blyth

Garscube Estate, Switchback Road
Glasgow, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 141 publications

Targeting RUNX1 protects against diastolic dysfunction in a two-hit mouse model of heart failure with preserved ejection fraction.

Targeting RUNX1 protects against diastolic dysfunction in a two-hit mouse model of heart failure with preserved ejection fraction.

Journal: Cardiovascular research
Published: June 24, 2025

Targeting RUNX1 protects against diastolic dysfunction in a two-hit mouse model of heart failure with preserved ejection fraction.

Targeting RUNX1 protects against diastolic dysfunction in a two-hit mouse model of heart failure with preserved ejection fraction.

Journal: Cardiovascular research
Published: June 24, 2025

Runx1 and Runx2 act in concert to suppress Wnt/β-catenin-driven mammary tumourigenesis.

Runx1 and Runx2 act in concert to suppress Wnt/β-catenin-driven mammary tumourigenesis.

Journal: British journal of cancer
Published: April 10, 2025

A precision image-guided model of stereotactic ablative radiotherapy for hepatocellular carcinoma.

A precision image-guided model of stereotactic ablative radiotherapy for hepatocellular carcinoma.

Journal: Disease models & mechanisms
Published: January 24, 2025

Inactivation of Histone Chaperone HIRA Unmasks a Link Between Normal Embryonic Development of Melanoblasts and Maintenance of Adult Melanocyte Stem Cells.

Inactivation of Histone Chaperone HIRA Unmasks a Link Between Normal Embryonic Development of Melanoblasts and Maintenance of Adult Melanocyte Stem Cells.

Journal: Aging cell
Published: January 10, 2025

Regulation of ROS signaling by TIGAR induces cancer-modulating responses in the tumor microenvironment.

Regulation of ROS signaling by TIGAR induces cancer-modulating responses in the tumor microenvironment.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 05, 2024

p53 and TIGAR promote redox control to protect against metabolic dysfunction-associated steatohepatitis.

p53 and TIGAR promote redox control to protect against metabolic dysfunction-associated steatohepatitis.

Journal: JHEP reports : innovation in hepatology
Published: November 11, 2024

AKT/mTOR as a targetable hub to overcome multimodal resistance to EGFR inhibitors in oesophageal squamous cell carcinoma.

AKT/mTOR as a targetable hub to overcome multimodal resistance to EGFR inhibitors in oesophageal squamous cell carcinoma.

Journal: British journal of cancer
Published: October 29, 2024

Locking CBL TKBD in its native conformation presents a novel therapeutic opportunity in mutant CBL-dependent leukemia.

Locking CBL TKBD in its native conformation presents a novel therapeutic opportunity in mutant CBL-dependent leukemia.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 13, 2024

Correction to: Brf1 loss and not overexpression disrupts tissues homeostasis in the intestine, liver and pancreas.

Correction to: Brf1 loss and not overexpression disrupts tissues homeostasis in the intestine, liver and pancreas.

Journal: Cell death and differentiation
Published: August 02, 2024

Integrin-dependent neutrophil slowing reduces lung perfusion and supports metastasis in a model of breast cancer.

Integrin-dependent neutrophil slowing reduces lung perfusion and supports metastasis in a model of breast cancer.

Journal: Cell reports
Published: August 02, 2024

Uridine phosphorylase-1 supports metastasis by altering immune and extracellular matrix landscapes.

Uridine phosphorylase-1 supports metastasis by altering immune and extracellular matrix landscapes.

Journal: EMBO reports
Published: July 02, 2024
Showing 1-12 of 141

Last Updated: 09/26/2026